You are here


Japan Inc shows promise with savvy holiday deal spree

Among promising signs for Japan's future are deals such as Asahi Glass's acquisition of drug maker CMC Biologics for 60 billion yen.

WHILE much attention has been focused on Japan's big ailing companies and their prospects for survival, a few small developments show some promising signs for the country's future.

Kicking off a week in deals, Asahi Glass Co said on Dec 20 it would buy CMC Biologics for 60 billion yen (S$...

Market voices on: